Organon (NYSE:OGN) reported quarterly earnings of $0.71 per share which missed the analyst consensus estimate of $0.83 by 14.46 percent. This is a 30.39 percent decrease over earnings of $1.02 per share from the same period last year. The company reported quarterly sales of $1.460 billion which missed the analyst consensus estimate of $1.484 billion by 1.63 percent. This is a 3.50 percent decrease over sales of $1.513 billion the same period last year.